版本:
中国

BRIEF-AGTC announces topline safety data for X-linked retinoschisis phase 1/2 study

June 8 Applied Genetic Technologies Corp

* AGTC announces topline safety data for X-linked retinoschisis phase 1/2 study

* ‍findings consistent with previous results demonstrating that investigational gene therapy for XLRS generally well tolerated​ Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐